The Naples Pediatric Food Allergy (NAPFA) Score
NAPFA
1 other identifier
observational
600
1 country
1
Brief Summary
Food Allergy (FA) is one of the most expensive allergic disorders in the pediatric age, and affecting up to 10% of children worldwide, it is recognized as a global health problem. The Oral Food Challenge (OFC) is the gold standard for FA diagnosis, but it is time-consuming, expensive, and potentially dangerous, as it can determine severe anaphylaxis. In addition, causing long-lasting impact on patient anxiety and mental health due to the physical duress and health risks involved with its application, OFC strategy is little applied in clinical practice with consequent diagnostic errors and delays. The goal of the Naples Pediatric Food Allergy (NAPFA) score is to develop a new clinical score including the main anamnestic, and clinical features for the easy identification of pediatric FA in primary care setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 23, 2023
CompletedStudy Start
First participant enrolled
January 23, 2023
CompletedFirst Posted
Study publicly available on registry
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 22, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2023
CompletedMay 14, 2025
May 1, 2025
5 months
January 23, 2023
May 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Development of a new clinical score for the identification of pediatric FA in primary care setting
The score will include the main anamnestic and clinical features
at the enrollment
Secondary Outcomes (2)
Development of a new clinical score for the identification of pediatric FA in secondary and tertiary care setting
at the enrollment
Validation of the new clinical NAPFA score for the identification of pediatric FA
at the enrollment
Study Arms (1)
Subject with suspected food allergy
Interventions
In subjects with suspected food allergy we will evaluate main anamnestic, and clinical features to develop the NAPFA score
Eligibility Criteria
Subjects consecutively observed at the Pediatric Allergy Program, at the Department of Translational Medical Science of the University of Naples Federico II, both sex, aged 0-14 years with suggestive history of food allergy
You may qualify if:
- subjects aged between 0-14 years with suggestive history of food allergy
You may not qualify if:
- chronic systemic diseases,
- malignancy,
- immunodeficiency,
- infectious diseases,
- autoimmune diseases,
- inflammatory bowel diseases,
- celiac disease,
- metabolic and genetic diseases,
- cystic fibrosis,
- chronic pulmonary diseases,
- gastrointestinal, respiratory, urinary tract and/or cardiovascular malformations,
- neurologic and/or neuropsychiatric disorders,
- gastrointestinal tract eosinophilic disorders,
- use of immunomodulating drugs in the previous 4 months
- use of steroids and antihistamines in the previous 2 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Traslational Medical Science - University of Naples Federico II
Naples, 80131, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roberto Berni Canani, MD
Department of Translational Medical Science, University of Naples Federico II
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pediatrics
Study Record Dates
First Submitted
January 23, 2023
First Posted
February 1, 2023
Study Start
January 23, 2023
Primary Completion
June 22, 2023
Study Completion
December 20, 2023
Last Updated
May 14, 2025
Record last verified: 2025-05